Literature DB >> 19383402

Identification of a membrane proteomic signature for human embryonic stem cells independent of culture conditions.

Linda Harkness1, Helle Christiansen, Jan Nehlin, Torben Barington, Jens S Andersen, Moustapha Kassem.   

Abstract

Proteomic profiling of human embryonic stem cells (hESC) can identify cell fate determination and self-renewal biomarkers. Employing Fourier transform LC-ESI-MS/MS and MS(3) mass spectrometry, we obtained a membrane proteomic signature overlapping between hESC cultured on mouse embryonic fibroblast (MEF) feeders and those grown under MEF-free culture conditions. We identified 444 transmembrane or membrane-associated proteins, of which 157 were common between both culture conditions. Functional annotation revealed CD antigens (10%), adhesion proteins (4%), proliferation-associated proteins (4%), receptors (41%), transport proteins (21%), structural proteins (5%), and proteins with miscellaneous functions (15%). In addition, 15 CD antigens and a number of surface marker molecules not previously observed in hESC at a proteome level, e.g., Nodal modulator 1, CD222, transgelin-2, and CD81, were identified. In conclusion, we describe the first membrane proteome profile of hESC that is independent of culture conditions. These data can be used to define the phenotype of hESC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19383402     DOI: 10.1016/j.scr.2008.06.001

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  8 in total

Review 1.  Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology.

Authors:  Rebekah L Gundry; Paul W Burridge; Kenneth R Boheler
Journal:  Proteomics       Date:  2011-09-08       Impact factor: 3.984

2.  Derivation and characterisation of hESC lines from supernumerary embryos, experience from Odense, Denmark.

Authors:  Linda Harkness; Iben Anne Rasmussen; Karin Erb; Moustapha Kassem
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-03-03       Impact factor: 2.416

Review 3.  The quest of cell surface markers for stem cell therapy.

Authors:  Anna Meyfour; Sara Pahlavan; Mehdi Mirzaei; Jeroen Krijgsveld; Hossein Baharvand; Ghasem Hosseini Salekdeh
Journal:  Cell Mol Life Sci       Date:  2020-07-24       Impact factor: 9.261

4.  Cell surface antigen profiling using a novel type of antibody array immobilised to plasma ion-implanted polycarbonate.

Authors:  Heather Main; Jelena Radenkovic; Elena Kosobrodova; David McKenzie; Marcela Bilek; Urban Lendahl
Journal:  Cell Mol Life Sci       Date:  2014-03-13       Impact factor: 9.261

5.  Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.

Authors:  Despina Soteriou; Banu Iskender; Adam Byron; Jonathan D Humphries; Simon Borg-Bartolo; Marie-Claire Haddock; Melissa A Baxter; David Knight; Martin J Humphries; Susan J Kimber
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

6.  Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and γ-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells.

Authors:  In-Gyu Kim; Jei-Ha Lee; Seo-Yeon Kim; Hai-Min Hwang; Tae-Rim Kim; Eun-Wie Cho
Journal:  Cancer Sci       Date:  2018-10-10       Impact factor: 6.716

7.  Media composition modulates human embryonic stem cell morphology and may influence preferential lineage differentiation potential.

Authors:  Linda Harkness; Xiaoli Chen; Marianne Gillard; Peter Paul Gray; Anthony Mitchell Davies
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

8.  Combining membrane proteomics and computational three-way pathway analysis revealed signalling pathways preferentially regulated in human iPSCs and human ESCs.

Authors:  Wei-Sheng Tien; Pei-Mien Chen; Ching-Yu Chuang; Shook-Mun Lui; Hung-Chih Kuo; Yu-Ju Chen; Kun-Pin Wu
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.